Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.58
NYSE:HUM's Cash to Debt is ranked higher than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.36 vs. NYSE:HUM: 1.58 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:HUM' s Cash to Debt Range Over the Past 10 Years
Min: 0.26  Med: 0.8 Max: N/A
Current: 1.58
Equity to Asset 0.38
NYSE:HUM's Equity to Asset is ranked higher than
54% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.32 vs. NYSE:HUM: 0.38 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:HUM' s Equity to Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.38 Max: 0.46
Current: 0.38
0.25
0.46
Interest Coverage 12.21
NYSE:HUM's Interest Coverage is ranked higher than
66% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.06 vs. NYSE:HUM: 12.21 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:HUM' s Interest Coverage Range Over the Past 10 Years
Min: 11.3  Med: 14.43 Max: 20.5
Current: 12.21
11.3
20.5
F-Score: 5
M-Score: -3.22
WACC vs ROIC
8.25%
25.52%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 4.16
NYSE:HUM's Operating margin (%) is ranked higher than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.14 vs. NYSE:HUM: 4.16 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:HUM' s Operating margin (%) Range Over the Past 10 Years
Min: 3.43  Med: 4.77 Max: 6.07
Current: 4.16
3.43
6.07
Net-margin (%) 2.00
NYSE:HUM's Net-margin (%) is ranked lower than
52% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.45 vs. NYSE:HUM: 2.00 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:HUM' s Net-margin (%) Range Over the Past 10 Years
Min: 2  Med: 3.05 Max: 3.85
Current: 2
2
3.85
ROE (%) 10.27
NYSE:HUM's ROE (%) is ranked lower than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.51 vs. NYSE:HUM: 10.27 )
Ranked among companies with meaningful ROE (%) only.
NYSE:HUM' s ROE (%) Range Over the Past 10 Years
Min: 10.27  Med: 16.28 Max: 23.54
Current: 10.27
10.27
23.54
ROA (%) 4.13
NYSE:HUM's ROA (%) is ranked higher than
59% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.81 vs. NYSE:HUM: 4.13 )
Ranked among companies with meaningful ROA (%) only.
NYSE:HUM' s ROA (%) Range Over the Past 10 Years
Min: 4.13  Med: 6.27 Max: 8.39
Current: 4.13
4.13
8.39
Revenue Growth (3Y)(%) 14.50
NYSE:HUM's Revenue Growth (3Y)(%) is ranked higher than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.70 vs. NYSE:HUM: 14.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:HUM' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.1  Med: 9.9 Max: 25.6
Current: 14.5
1.1
25.6
EBITDA Growth (3Y)(%) 12.10
NYSE:HUM's EBITDA Growth (3Y)(%) is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.50 vs. NYSE:HUM: 12.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:HUM' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -9.5  Med: 14.7 Max: 38.5
Current: 12.1
-9.5
38.5
EPS Growth (3Y)(%) 4.20
NYSE:HUM's EPS Growth (3Y)(%) is ranked lower than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.10 vs. NYSE:HUM: 4.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:HUM' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -19.9  Med: 27 Max: 41.9
Current: 4.2
-19.9
41.9
» NYSE:HUM's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

HUM Guru Trades in Q4 2015

Eric Mindich 364,285 sh (New)
Louis Moore Bacon 11,874 sh (New)
David Einhorn 360,000 sh (New)
Joel Greenblatt 6,890 sh (+37.36%)
Larry Robbins 8,250,929 sh (+24.35%)
Andreas Halvorsen 4,331,936 sh (+12.42%)
Mario Gabelli 9,620 sh (+12.12%)
Jim Simons 128,800 sh (+4.21%)
Vanguard Health Care Fund Sold Out
John Burbank Sold Out
Paul Tudor Jones Sold Out
HOTCHKIS & WILEY 987,067 sh (-3.07%)
Jeremy Grantham 1,128,679 sh (-17.46%)
Pioneer Investments 319,616 sh (-64.03%)
» More
Q1 2016

HUM Guru Trades in Q1 2016

George Soros 78,763 sh (New)
Steven Cohen 36,400 sh (New)
Jim Simons 446,000 sh (+246.27%)
Pioneer Investments 557,105 sh (+74.30%)
Mario Gabelli 16,743 sh (+74.04%)
David Einhorn 384,300 sh (+6.75%)
Eric Mindich Sold Out
Louis Moore Bacon Sold Out
HOTCHKIS & WILEY 972,785 sh (-1.45%)
Larry Robbins 6,424,777 sh (-22.13%)
Jeremy Grantham 743,379 sh (-34.14%)
Joel Greenblatt 3,382 sh (-50.91%)
Andreas Halvorsen 1,228,373 sh (-71.64%)
» More
Q2 2016

HUM Guru Trades in Q2 2016

Mario Gabelli 27,070 sh (+61.68%)
Jim Simons 706,800 sh (+58.48%)
Larry Robbins 8,668,249 sh (+34.92%)
Joel Greenblatt 3,699 sh (+9.37%)
Pioneer Investments 586,827 sh (+5.34%)
Jeremy Grantham 125,900 sh (unchged)
David Einhorn 384,300 sh (unchged)
Steven Cohen Sold Out
HOTCHKIS & WILEY 964,959 sh (-0.80%)
Jeremy Grantham 655,782 sh (-11.78%)
Andreas Halvorsen 811,824 sh (-33.91%)
George Soros 37,833 sh (-51.97%)
» More
Q3 2016

HUM Guru Trades in Q3 2016

Diamond Hill Capital 228,660 sh (New)
Daniel Loeb 1,400,000 sh (New)
Paul Tudor Jones 103,861 sh (New)
Steven Cohen 32,700 sh (New)
John Paulson 79,500 sh (New)
Joel Greenblatt 10,396 sh (+181.05%)
Jim Simons 913,704 sh (+29.27%)
Larry Robbins 9,529,175 sh (+9.93%)
Jeremy Grantham 343,000 sh (unchged)
George Soros 82,700 sh (unchged)
David Einhorn Sold Out
George Soros Sold Out
Mario Gabelli 26,945 sh (-0.46%)
Jeremy Grantham 649,537 sh (-0.95%)
Pioneer Investments 550,039 sh (-6.27%)
Andreas Halvorsen 640,646 sh (-21.09%)
HOTCHKIS & WILEY 527,545 sh (-45.33%)
» More
» Details

Insider Trades

Latest Guru Trades with HUM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:NYSE:CI, NYSE:ANTM, NYSE:AET, NAS:ESRX, NYSE:CNC, NYSE:WCG, NYSE:MOH, OTCPK:ODPVY, NAS:MGLN, NYSE:UAM, NAS:HIIQ, NAS:CNXR, OTCPK:OPRX, OTCPK:WCUI, NYSE:CVS, NYSE:UNH » details
Traded in other countries:HUM.Germany,
Humana Inc is a health care company that offers a insurance products and health and wellness services. Its segments include Retail, Employer Group, and Healthcare Services.

Humana Inc was organized as a Delaware corporation in 1964. The Company is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services. These segments are based on a combination of the type of health plan customer and adjacent businesses centered on integrated care delivery for its health plans and other customers. The Retail segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision and other supplemental health and financial protection products, marketed directly to individuals, and includes its contract with Centers for Medicare and Medicaid Services, or CMS, to administer the LI-NET prescription drug plan program and contracts with various states to provide Medicaid, dual eligible, and Long-Term Support Services benefits, collectively its state-based contracts. The Employer Group segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision and other supplemental health and voluntary benefit products, as well as administrative services only products, or ASO, and its health and wellness products marketed to employer groups. The Healthcare Services segment includes services offered to its health plan members as well as to third parties, including pharmacy, provider services, home based services, integrated behavioral health services, and predictive modeling and informatics services. The Other Business category consists of its military services. Its TRICARE South Region contract, Puerto Rico Medicaid, and closed-block long-term care insurance policies. The Company's competitors vary by local market and include other managed care companies, national insurance companies, and other HMOs and PPOs, including HMOs and PPOs owned by Blue Cross/Blue Shield plans.

Top Ranked Articles about Humana Inc

Larry Robbins Continues to Invest in Acquisition Targets Robbins ups his stakes in healthcare and media mergers
Noted health care investor Larry Robbins (Trades, Portfolio) of Glenview Capital added to his stake in at least three companies that are currently the targets in mega mergers. All three deals are also under intense scrutiny from regulators. Read more...
Vanguard Health Care Fund Sells Stake in Humana Guru raises stakes in Allergan, Aetna and Cigna
The Vanguard Health Care Fund (Trades, Portfolio), which, as its name suggests, invests almost exclusively in health care companies, made five new buys in the fourth quarter, but its most significant transaction was the sale of its 4,716,539-share stake in Humana Inc. (NYSE:HUM), a Louisville, Kentucky-based health insurance company. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 27.77
HUM's P/E(ttm) is ranked lower than
95% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.11 vs. HUM: 27.77 )
Ranked among companies with meaningful P/E(ttm) only.
HUM' s P/E(ttm) Range Over the Past 10 Years
Min: 4.26  Med: 11.16 Max: 34.62
Current: 27.77
4.26
34.62
Forward P/E 19.12
HUM's Forward P/E is ranked lower than
83% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.71 vs. HUM: 19.12 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 27.77
HUM's PE(NRI) is ranked lower than
95% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.17 vs. HUM: 27.77 )
Ranked among companies with meaningful PE(NRI) only.
HUM' s PE(NRI) Range Over the Past 10 Years
Min: 4.26  Med: 11.16 Max: 34.62
Current: 27.77
4.26
34.62
Price/Owner Earnings (ttm) 6.99
HUM's Price/Owner Earnings (ttm) is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.34 vs. HUM: 6.99 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HUM' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 2.73  Med: 7.46 Max: 76.26
Current: 6.99
2.73
76.26
P/B 2.64
HUM's P/B is ranked lower than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.54 vs. HUM: 2.64 )
Ranked among companies with meaningful P/B only.
HUM' s P/B Range Over the Past 10 Years
Min: 0.71  Med: 1.81 Max: 3.82
Current: 2.64
0.71
3.82
P/S 0.56
HUM's P/S is ranked lower than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.49 vs. HUM: 0.56 )
Ranked among companies with meaningful P/S only.
HUM' s P/S Range Over the Past 10 Years
Min: 0.11  Med: 0.39 Max: 0.66
Current: 0.56
0.11
0.66
PFCF 6.75
HUM's PFCF is ranked higher than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.70 vs. HUM: 6.75 )
Ranked among companies with meaningful PFCF only.
HUM' s PFCF Range Over the Past 10 Years
Min: 2.75  Med: 7.14 Max: 674.15
Current: 6.75
2.75
674.15
POCF 6.06
HUM's POCF is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.07 vs. HUM: 6.06 )
Ranked among companies with meaningful POCF only.
HUM' s POCF Range Over the Past 10 Years
Min: 2.49  Med: 6.13 Max: 53.29
Current: 6.06
2.49
53.29
EV-to-EBIT 8.21
HUM's EV-to-EBIT is ranked higher than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.11 vs. HUM: 8.21 )
Ranked among companies with meaningful EV-to-EBIT only.
HUM' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.7  Med: 3.6 Max: 16.1
Current: 8.21
-0.7
16.1
EV-to-EBITDA 6.94
HUM's EV-to-EBITDA is ranked higher than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.52 vs. HUM: 6.94 )
Ranked among companies with meaningful EV-to-EBITDA only.
HUM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.6  Med: 3.1 Max: 12.6
Current: 6.94
-0.6
12.6
PEG 3.38
HUM's PEG is ranked lower than
86% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.37 vs. HUM: 3.38 )
Ranked among companies with meaningful PEG only.
HUM' s PEG Range Over the Past 10 Years
Min: 0.15  Med: 0.63 Max: 4.66
Current: 3.38
0.15
4.66
Shiller P/E 27.72
HUM's Shiller P/E is ranked higher than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.34 vs. HUM: 27.72 )
Ranked among companies with meaningful Shiller P/E only.
HUM' s Shiller P/E Range Over the Past 10 Years
Min: 10.68  Med: 21.02 Max: 63.04
Current: 27.72
10.68
63.04

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.57
HUM's Dividend Yield is ranked lower than
81% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.24 vs. HUM: 0.57 )
Ranked among companies with meaningful Dividend Yield only.
HUM' s Dividend Yield Range Over the Past 10 Years
Min: 0.3  Med: 0.84 Max: 1.61
Current: 0.57
0.3
1.61
Dividend Payout 0.12
HUM's Dividend Payout is ranked higher than
73% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. HUM: 0.12 )
Ranked among companies with meaningful Dividend Payout only.
HUM' s Dividend Payout Range Over the Past 10 Years
Min: 0.09  Med: 0.12 Max: 0.43
Current: 0.12
0.09
0.43
Dividend Growth (3y) 3.70
HUM's Dividend Growth (3y) is ranked lower than
63% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.60 vs. HUM: 3.70 )
Ranked among companies with meaningful Dividend Growth (3y) only.
HUM' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 14
Current: 3.7
0
14
Forward Dividend Yield 0.57
HUM's Forward Dividend Yield is ranked lower than
92% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.21 vs. HUM: 0.57 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.57
HUM's Yield on cost (5-Year) is ranked lower than
89% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.52 vs. HUM: 0.57 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HUM' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.3  Med: 0.84 Max: 1.61
Current: 0.57
0.3
1.61
3-Year Average Share Buyback Ratio 2.20
HUM's 3-Year Average Share Buyback Ratio is ranked higher than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.20 vs. HUM: 2.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HUM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2  Med: 0.3 Max: 3
Current: 2.2
-2
3

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.81
HUM's Price/Tangible Book is ranked higher than
60% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.11 vs. HUM: 3.81 )
Ranked among companies with meaningful Price/Tangible Book only.
HUM' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.32  Med: 3 Max: 12.29
Current: 3.81
1.32
12.29
Price/Projected FCF 0.92
HUM's Price/Projected FCF is ranked lower than
55% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.96 vs. HUM: 0.92 )
Ranked among companies with meaningful Price/Projected FCF only.
HUM' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.3  Med: 0.77 Max: 2.15
Current: 0.92
0.3
2.15
Price/DCF (Earnings Based) 1.48
HUM's Price/DCF (Earnings Based) is ranked lower than
67% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.27 vs. HUM: 1.48 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.44
HUM's Price/Median PS Value is ranked lower than
92% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.07 vs. HUM: 1.44 )
Ranked among companies with meaningful Price/Median PS Value only.
HUM' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.36  Med: 0.95 Max: 2.5
Current: 1.44
0.36
2.5
Price/Peter Lynch Fair Value 4.40
HUM's Price/Peter Lynch Fair Value is ranked lower than
100% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.22 vs. HUM: 4.40 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HUM' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.23  Med: 0.66 Max: 4.59
Current: 4.4
0.23
4.59
Price/Graham Number 2.18
HUM's Price/Graham Number is ranked higher than
50% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.28 vs. HUM: 2.18 )
Ranked among companies with meaningful Price/Graham Number only.
HUM' s Price/Graham Number Range Over the Past 10 Years
Min: 0.65  Med: 1.52 Max: 6.81
Current: 2.18
0.65
6.81
Earnings Yield (Greenblatt) (%) 12.17
HUM's Earnings Yield (Greenblatt) (%) is ranked higher than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. HUM: 12.17 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HUM' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.2  Med: 27.9 Max: 4111
Current: 12.17
6.2
4111
Forward Rate of Return (Yacktman) (%) 11.78
HUM's Forward Rate of Return (Yacktman) (%) is ranked lower than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.58 vs. HUM: 11.78 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HUM' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.7  Med: 27.2 Max: 51.5
Current: 11.78
9.7
51.5

More Statistics

Revenue (TTM) (Mil) $54,862
EPS (TTM) $ 7.27
Beta0.89
Short Percentage of Float1.63%
52-Week Range $150.00 - 217.80
Shares Outstanding (Mil)149.10

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 54,728 55,167 58,304
EPS ($) 9.16 10.39 12.07
EPS w/o NRI ($) 9.16 10.39 12.07
EPS Growth Rate
(3Y to 5Y Estimate)
42.70%
Dividends Per Share ($) 1.15 1.15 1.16
» More Articles for HUM

Headlines

Articles On GuruFocus.com
Hotchkis & Wiley Trims Corning, Microsoft, Exits HP Dec 05 2016 
Aetna the Undaunted Insurer Oct 31 2016 
The Big 3: Larry Robbins' Top 2nd-Quarter Buys Aug 16 2016 
Cigna Is An Excellent Prospect, Regardless of Anthem Deal Jul 17 2016 
Express Scripts: Is This a Value Investing Opportunity or a Legal Quagmire? Jun 08 2016 
The Waiting Is the Hardest Part Feb 23 2016 
Larry Robbins Continues to Invest in Acquisition Targets Feb 18 2016 
Is This the Time to Buy Insurance Companies? Feb 16 2016 
Vanguard Health Care Fund Sells Stake in Humana Feb 03 2016 
Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Dec 06 2015 

More From Other Websites
FullWell Enters into New Value-Based Agreement with Humana in Colorado Dec 07 2016
Will Trump Era Mean Disaster for Health Insurers? Dec 07 2016
Humana downgraded by Cantor Fitzgerald Dec 07 2016
Humana Tops Inaugural JUST 100 List in Health Care Providers and Services Sector, Published by JUST... Dec 06 2016
DOJ, Aetna Lawyers Preview Their Upcoming Duel Over Planned Sale to Molina Dec 06 2016
If Paul Ryan Privatizes Medicare, Aetna-Humana Trial Looms Larger Dec 06 2016
Lawyer in Humana-Aetna case: Government arguing about 'a pretend world' Dec 06 2016
[$$] Aetna and Humana Defend Merger, as Antitrust Trial Begins Dec 06 2016
U.S. attorneys argue Aetna-Humana deal violates antitrust law Dec 05 2016
The Biggest Loser: Aetna Slumps 3% Dec 05 2016
[$$] Aetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins Dec 05 2016
UnitedHealth, The Amazon Of Health Care, Isn't Sweating Trump Dec 05 2016
U.S. attorney argues Aetna-Humana deal violates antitrust law: trial Dec 05 2016
Read the statement: American Medical Association president opposes Aetna-Humana merger Dec 05 2016
U.S. attorneys argue Aetna-Humana deal violates antitrust law - Trial Dec 05 2016
Next Up: Aetna Defends Its $37 Billion Bid for Humana Dec 05 2016
Aetna’s Remedy to Salvage Humana Deal Draws Fire From U.S. Dec 05 2016
5 Healthcare Stocks Billionaires Love The Most Dec 04 2016
To Fix Obamacare, Double Down On Population Health Dec 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)